Page last updated: 2024-10-29

ketamine and Hemiplegia, Crossed

ketamine has been researched along with Hemiplegia, Crossed in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research Excerpts

ExcerptRelevanceReference
" The N-methyl-D-aspartate (NMDA) receptor noncompetitive antagonist ketamine has been proved to be effective terminating status epilepticus (SE) in animal models and human case studies."7.96Ketamine Infusion for Super Refractory Status Epilepticus in Alternating Hemiplegia of Childhood. ( Samanta, D, 2020)
" The N-methyl-D-aspartate (NMDA) receptor noncompetitive antagonist ketamine has been proved to be effective terminating status epilepticus (SE) in animal models and human case studies."3.96Ketamine Infusion for Super Refractory Status Epilepticus in Alternating Hemiplegia of Childhood. ( Samanta, D, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Samanta, D1

Other Studies

1 other study available for ketamine and Hemiplegia, Crossed

ArticleYear
Ketamine Infusion for Super Refractory Status Epilepticus in Alternating Hemiplegia of Childhood.
    Neuropediatrics, 2020, Volume: 51, Issue:3

    Topics: Child; Child, Preschool; Excitatory Amino Acid Antagonists; Female; Hemiplegia; Humans; Ketamine; Ma

2020